306 related articles for article (PubMed ID: 33857549)
1. Microneedling as an adjuvant to topical therapies for melasma: A systematic review and meta-analysis.
Bailey AJM; Li HO; Tan MG; Cheng W; Dover JS
J Am Acad Dermatol; 2022 Apr; 86(4):797-810. PubMed ID: 33857549
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and safety of topical tranexamic acid (liposomal or lotion with microneedling) versus conventional hydroquinone in the treatment of melasma.
Xing X; Chen L; Xu Z; Jin S; Zhang C; Xiang L
J Cosmet Dermatol; 2020 Dec; 19(12):3238-3244. PubMed ID: 33091202
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of tranexamic acid versus vitamin c after microneedling in treatment of melasma: Clinical and Dermoscopic study.
El Attar Y; Doghaim N; El Far N; El Hedody S; Hawwam SA
J Cosmet Dermatol; 2022 Jul; 21(7):2817-2825. PubMed ID: 34699671
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and safety of microneedling with topical tranexamic acid for melasma treatment: A systematic review and meta-analysis.
Feng X; Su H; Xie J
J Cosmet Dermatol; 2024 Jan; 23(1):33-43. PubMed ID: 37584240
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of microneedling plus topical 4% tranexamic acid solution vs 4% hydroquinone in the treatment of melasma: A single-blind randomized clinical trial.
Shamsi Meymandi S; Mozayyeni A; Shamsi Meymandi M; Aflatoonian M
J Cosmet Dermatol; 2020 Nov; 19(11):2906-2911. PubMed ID: 32406162
[TBL] [Abstract][Full Text] [Related]
6. A prospective randomized controlled trial of Q-switched Nd:YAG laser with topical 3% tranexamic acid (TA) versus microneedling with topical 3% tranexamic acid (TA) in treatment of melasma.
Debasmita B; Raj C; Ishan A; Ipsita D
J Cosmet Dermatol; 2022 Jul; 21(7):2801-2807. PubMed ID: 34636493
[TBL] [Abstract][Full Text] [Related]
7. Microneedling with cutaneous delivery of topical agents for the treatment of melasma: A systematic review.
Brasil Dos Santos J; Nagem Lopes LP; de Lima GG; Teixeira da Silva R; da Silva E Souza Lorca B; Miranda Pinheiro G; Faria de Freitas ZM
J Cosmet Dermatol; 2022 Nov; 21(11):5680-5695. PubMed ID: 35933690
[TBL] [Abstract][Full Text] [Related]
8. Microneedling-assisted topical tranexamic acid solution versus 4% hydroquinone for treating melasma: A split-face randomized study.
Zaky MS; Obaid ZM; Khalil EA; Elsaie ML
J Cosmet Dermatol; 2021 Dec; 20(12):4011-4016. PubMed ID: 34525492
[TBL] [Abstract][Full Text] [Related]
9. Histological changes in facial melasma after treatment with triple combination cream with or without oral tranexamic acid and/or microneedling: A randomised clinical trial.
Cassiano DP; EspĆ³sito ACC; Hassun KM; Lima MMDA; Lima EVA; Miot LDB; Miot HA; Bagatin E
Indian J Dermatol Venereol Leprol; 2022; 88(6):761-770. PubMed ID: 35389028
[TBL] [Abstract][Full Text] [Related]
10. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
[TBL] [Abstract][Full Text] [Related]
11. Melasma treatment: a systematic review.
Neagu N; Conforti C; Agozzino M; Marangi GF; Morariu SH; Pellacani G; Persichetti P; Piccolo D; Segreto F; Zalaudek I; Dianzani C
J Dermatolog Treat; 2022 Jun; 33(4):1816-1837. PubMed ID: 33849384
[TBL] [Abstract][Full Text] [Related]
12. Tranexamic acid in melasma: A focused review on drug administration routes.
Konisky H; Balazic E; Jaller JA; Khanna U; Kobets K
J Cosmet Dermatol; 2023 Apr; 22(4):1197-1206. PubMed ID: 36606378
[TBL] [Abstract][Full Text] [Related]
13. Treatment of melasma with topical agents, peels and lasers: an evidence-based review.
Rivas S; Pandya AG
Am J Clin Dermatol; 2013 Oct; 14(5):359-76. PubMed ID: 23881551
[TBL] [Abstract][Full Text] [Related]
14. Randomized, double-blind, placebo-controlled split-face trial of the efficacy of tranexamic acid by drug delivery through microneedling in the treatment of melasma.
Kuster Kaminski Arida D; Orso Rebellato PR; Marioto de Campos GL; Costa A; Vilaverde Schmitt J; Larocca Skare T; Rodrigues Lisboa Faucz L
J Cosmet Dermatol; 2021 Dec; 20(12):4005-4010. PubMed ID: 34077619
[TBL] [Abstract][Full Text] [Related]
15. A Systematic Review of the Efficacy and Safety of Microneedling in the Treatment of Melasma.
Wu SZ; Muddasani S; Alam M
Dermatol Surg; 2020 Dec; 46(12):1636-1641. PubMed ID: 32897944
[TBL] [Abstract][Full Text] [Related]
16. Clinical Efficacy of Topical Tranexamic Acid With Microneedling in Melasma.
Kaur A; Bhalla M; Pal Thami G; Sandhu J
Dermatol Surg; 2020 Nov; 46(11):e96-e101. PubMed ID: 32769524
[TBL] [Abstract][Full Text] [Related]
17. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma.
Ustuner P; Balevi A; Ozdemir M
J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378
[TBL] [Abstract][Full Text] [Related]
18. Systematic review of clinical studies assessing the needling for treatment of melasma: Focusing on efficacy, safety, and recurrence rate.
Sadeghzadeh-Bazargan A; Behrangi E; Najar Nobari N; Ghassemi M; Roohaninasab M; Goodarzi A
J Cosmet Dermatol; 2022 May; 21(5):1857-1873. PubMed ID: 35146868
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor- and analyst-blinded, randomized controlled trial with a short-term follow-up.
Lajevardi V; Ghayoumi A; Abedini R; Hosseini H; Goodarzi A; Akbari Z; Hedayat K
J Cosmet Dermatol; 2017 Jun; 16(2):235-242. PubMed ID: 27762489
[TBL] [Abstract][Full Text] [Related]
20. Dermoscopic evaluation of tranexamic acid versus Vitamin C, with microneedling in the treatment of melasma: a comparative, split-face, single-blinded study.
Tahoun AI; Mostafa WZ; Amer MA
J Dermatolog Treat; 2022 May; 33(3):1623-1629. PubMed ID: 33393842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]